Press ReleaseActive Biotech expands US collaboration to advance tasquinimod clinical development in myelofibrosis
Press ReleaseEuropean regulatory approval obtained to resume enrolment in the HOVON 172 MF study evaluating tasquinimod in myelofibrosis and conducted in collaboration between Active Biotech, Oncode and HOVON
Press ReleaseActive Biotech publishes results from the LION study on ocular absorption and distribution of laquinimod in the eye
Press ReleaseActive Biotech receives positive feedback on its clinical study with tasquinimod in myelofibrosis
Press ReleaseActive Biotech’s patent related to a pharmaceutical formulation of tasquinimod will be granted in the US
Press ReleasePreclinical data of tasquinimod in combination with T cell activation to be presented at ASH 2025
Press ReleasePositive results from Active Biotech’s clinical phase I LION study to be presented at AAO 2025 in October
